ArticleESMO open2022

Early on-treatment tumor growth rate (EOT-TGR) determines treatment outcomes of advanced non-small-cell lung cancer patients treated with programmed cell death protein 1 axis inhibitor.

L-N He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.